Your browser doesn't support javascript.
loading
Activity and safety of the multi-target tyrosine kinase inhibitor cabozantinib in patients with metastatic gastrointestinal stromal tumour after treatment with imatinib and sunitinib: European Organisation for Research and Treatment of Cancer phase II trial 1317 'CaboGIST'.
Schöffski, Patrick; Mir, Olivier; Kasper, Bernd; Papai, Zsuzsanna; Blay, Jean-Yves; Italiano, Antoine; Benson, Charlotte; Kopeckova, Katerina; Ali, Nasim; Dileo, Palma; LeCesne, Axel; Menge, Franka; Cousin, Sophie; Wardelmann, Eva; Wozniak, Agnieszka; Marreaud, Sandrine; Litiere, Saskia; Zaffaroni, Facundo; Nzokirantevye, Axelle; Vanden Bempt, Isabelle; Gelderblom, Hans.
Afiliação
  • Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, and Department of Oncology, KU Leuven, Laboratory of Experimental Oncology, Leuven, Belgium. Electronic address: patrick.schoffski@uzleuven.be.
  • Mir O; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Kasper B; Sarcoma Unit, Interdisciplinary Tumor Center Mannheim, Mannheim University Medical Center, Mannheim, Germany.
  • Papai Z; State Health Center, Oncology Department, Budapest, Hungary.
  • Blay JY; Department of Medical Oncology, Centre Léon Bérard, NETSARC+, LYRICAN, and Université Claude Bernard Lyon I, Lyon, France.
  • Italiano A; Sarcoma Unit, Institut Bergonié, Bordeaux, France.
  • Benson C; Royal Marsden Hospital, London, United Kingdom.
  • Kopeckova K; Department of Oncology, Motol University Hospital, Czech Republic.
  • Ali N; Clatterbridge Cancer Centre, Wirral, United Kingdom.
  • Dileo P; Sarcoma Unit, University College London, United Kingdom.
  • LeCesne A; Department of Medical Oncology, Gustave Roussy, Villejuif, France.
  • Menge F; Sarcoma Unit, Interdisciplinary Tumor Center Mannheim, Mannheim University Medical Center, Mannheim, Germany.
  • Cousin S; Sarcoma Unit, Institut Bergonié, Bordeaux, France.
  • Wardelmann E; University Hospital, Münster, Germany.
  • Wozniak A; Department of General Medical Oncology, University Hospitals Leuven, Leuven Cancer Institute, and Department of Oncology, KU Leuven, Laboratory of Experimental Oncology, Leuven, Belgium.
  • Marreaud S; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Litiere S; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Zaffaroni F; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Nzokirantevye A; European Organization for Research and Treatment of Cancer, Brussels, Belgium.
  • Vanden Bempt I; Department of Human Genetics, KU Leuven, University Hospitals Leuven, Leuven, Belgium.
  • Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.
Eur J Cancer ; 134: 62-74, 2020 07.
Article em En | MEDLINE | ID: mdl-32470848

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Tumores do Estroma Gastrointestinal / Inibidores de Proteínas Quinases / Neoplasias Gastrointestinais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Resistencia a Medicamentos Antineoplásicos / Tumores do Estroma Gastrointestinal / Inibidores de Proteínas Quinases / Neoplasias Gastrointestinais Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article